$Sonoma Pharmaceuticals (SNOA.US)$
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
Thursday, 5th December at 8:30 am
BOULDER, CO / ACCESSWIRE / December 5, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, d...

$Sonoma Pharmaceuticals (SNOA.US)$ Sonoma Pharmaceuticals Terminates Agreement With EMC Pharma After It Did Not Meet Minimum Purchase Requirements

$Sonoma Pharmaceuticals (SNOA.US)$ Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
4 MINUTES AGO, 4:06 PM EST
VIA ACCESSWIRE

$Sonoma Pharmaceuticals (SNOA.US)$ Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
Accesswire· 7 mins ago

$Revelation Biosciences (REVB.US)$ $Nukkleus (NUKK.US)$ $Lm Funding America (LMFA.US)$ $Sonoma Pharmaceuticals (SNOA.US)$ $Vertical Aerospace (EVTL.US)$ $Advent Technologies (ADN.US)$ $Avalon Holdings (AWX.US)$ $LakeShore Biopharma (LSB.US)$ $Vicarious Surgical (RBOT.US)$ $Protagenic Therapeutics (PTIX.US)$ $Cingulate (CING.US)$ $BTC Digital (BTCT.US)$ $SemiLEDs (LEDS.US)$ $SU Group Holdings (SUGP.US)$
📊⚡️📊

$Sonoma Pharmaceuticals (SNOA.US)$ Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
4 MINUTES AGO, 8:35 AM EDT
VIA ACCESSWIRE